VALIANTLABNSEValiant Laboratories LimitedMediumNeutral
Announced Wed, 16 Jul · 16:18 IST

Valiant Laboratories Limited has informed the Exchange regarding 'ISIN for Rights Entitlements for Rights Issue'.

Corporate Actions View source PDF

VALIANTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Valiant Laboratories Limited has informed the exchanges about the ISIN (INE0JWS20017) assigned to the Rights Entitlements for its upcoming Rights Issue. The company has arranged with NSDL and CDSL to credit these Rights Entitlements in demat accounts of eligible equity shareholders before the issue opening date. The intimation has been made in line with SEBI's Rights Issue circulars. No details on issue price, ratio, or record date are included in this filing.

Likely market impact

This is a procedural update confirming that the company is moving ahead with a Rights Issue. Existing shareholders will receive Rights Entitlements in their demat accounts but will need to watch for further announcements on issue price, ratio, and record date to assess the actual cost and attractiveness of the offer.